These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8961058)

  • 1. Enteric absorption of ciprofloxacin during tube feeding in the critically ill.
    Cohn SM; Sawyer MD; Burns GA; Tolomeo C; Milner KA
    J Antimicrob Chemother; 1996 Nov; 38(5):871-6. PubMed ID: 8961058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients.
    Mimoz O; Binter V; Jacolot A; Edouard A; Tod M; Petitjean O; Samii K
    Intensive Care Med; 1998 Oct; 24(10):1047-51. PubMed ID: 9840238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes.
    Healy DP; Brodbeck MC; Clendening CE
    Antimicrob Agents Chemother; 1996 Jan; 40(1):6-10. PubMed ID: 8787869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteric absorption of ciprofloxacin during the immediate postoperative period.
    Cohn SM; Cohn KA; Rafferty MJ; Smith AH; Degutis LC; Kowalsky SF; Shah A
    J Antimicrob Chemother; 1995 Oct; 36(4):717-21. PubMed ID: 8591948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic parameters of ciprofloxacin (500 mg/5 mL) oral suspension in critically ill patients with severe bacterial pneumonia: a comparison of two dosages.
    Debon R; Breilh D; Boselli E; Saux MC; Duflo F; Chassard D; Allaouchiche B
    J Chemother; 2002 Apr; 14(2):175-80. PubMed ID: 12017373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of ciprofloxacin after multiple enteral and intravenous doses in ICU patients with severe gram-negative intra-abdominal infections.
    de Marie S; VandenBergh MF; Buijk SL; Bruining HA; van Vliet A; Kluytmans JA; Mouton JW
    Intensive Care Med; 1998 Apr; 24(4):343-6. PubMed ID: 9609412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and burn eschar penetration of intravenous ciprofloxacin in patients with major thermal injuries.
    Varela JE; Cohn SM; Brown M; Ward CG; Namias N; Spalding PB
    J Antimicrob Chemother; 2000 Mar; 45(3):337-42. PubMed ID: 10702553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of gatifloxacin by gastric tube administration with and without concomitant enteral feeding in critically ill patients.
    Kanji S; McKinnon PS; Barletta JF; Kruse JA; Devlin JW
    Crit Care Med; 2003 May; 31(5):1347-52. PubMed ID: 12771601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of ciprofloxacin in critically ill patients after the first intravenous administration of 400 mg.
    Szałek E; Tomczak H; Kamińska A; Grabowski T; Smuszkiewicz P; Matysiak K; Wolc A; Kaczmarek Z; Grześkowiak E
    Adv Med Sci; 2012; 57(2):217-23. PubMed ID: 22968336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.
    Wallis SC; Mullany DV; Lipman J; Rickard CM; Daley PJ
    Intensive Care Med; 2001 Apr; 27(4):665-72. PubMed ID: 11398692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of oral ciprofloxacin in early postsurgical patients.
    Hackam DJ; Christou N; Khaliq Y; Duffy DR; Vaughan D; Marshall JC; Rotstein OD
    Arch Surg; 1998 Nov; 133(11):1221-5. PubMed ID: 9820354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs.
    Papich MG
    Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous pharmacokinetics of ciprofloxacin in goats.
    García Ovando H; Gorla N; Poloni G; Trotti N; Prieto G; Errecalde C
    Int J Antimicrob Agents; 2000 Jun; 15(1):77-9. PubMed ID: 10856681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feeding.
    Yuk JH; Nightingale CH; Sweeney KR; Quintiliani R; Lettieri JT; Frost RW
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1118-20. PubMed ID: 2506806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin concentrations in lung tissue following a single 400 mg intravenous dose.
    Birmingham MC; Guarino R; Heller A; Wilton JH; Shah A; Hejmanowski L; Nix DE; Schentag JJ
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():43-8. PubMed ID: 10225571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption of ciprofloxacin administered through a nasogastric or a nasoduodenal tube in volunteers and patients receiving enteral nutrition.
    Yuk JH; Nightingale CH; Quintiliani R; Yeston NS; Orlando R; Dobkin ED; Kambe JC; Sweeney KR; Buonpane EA
    Diagn Microbiol Infect Dis; 1990; 13(2):99-102. PubMed ID: 2114955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin pharmacokinetics in young cystic fibrosis patients after repeated oral doses.
    Odoul F; Le Guellec C; Giraut C; de Gialluly C; Marchand S; Paintaud G; Saux MC; Rolland JC; Autret-Leca E
    Therapie; 2001; 56(5):519-24. PubMed ID: 11806288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin and norfloxacin pharmacokinetics and prostatic fluid penetration in dogs after multiple oral dosing.
    Albarellos GA; Montoya L; Waxman S; Kreil V; Ambros LA; Hallu R; Rebuelto M
    Vet J; 2006 Sep; 172(2):334-9. PubMed ID: 15994101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
    Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
    Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.